Novartis AG (NVSEF)
101.99
+5.31
(+5.49%)
USD |
OTCM |
May 10, 15:56
Novartis Market Cap: 208.10B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 197.27B |
| May 08, 2024 | 203.10B |
| May 07, 2024 | 196.43B |
| May 06, 2024 | 194.31B |
| May 03, 2024 | 193.31B |
| May 02, 2024 | 197.92B |
| May 01, 2024 | 197.92B |
| April 30, 2024 | 197.92B |
| April 29, 2024 | 195.88B |
| April 26, 2024 | 195.88B |
| April 25, 2024 | 195.88B |
| April 24, 2024 | 195.88B |
| April 23, 2024 | 195.88B |
| April 22, 2024 | 194.06B |
| April 19, 2024 | 184.13B |
| April 18, 2024 | 184.13B |
| April 17, 2024 | 191.06B |
| April 16, 2024 | 191.06B |
| April 15, 2024 | 191.06B |
| April 12, 2024 | 191.06B |
| April 11, 2024 | 191.06B |
| April 10, 2024 | 192.00B |
| April 09, 2024 | 195.27B |
| April 08, 2024 | 193.65B |
| April 05, 2024 | 193.65B |
| Date | Value |
|---|---|
| April 04, 2024 | 193.65B |
| April 03, 2024 | 188.62B |
| April 02, 2024 | 193.84B |
| April 01, 2024 | 196.92B |
| March 28, 2024 | 197.27B |
| March 27, 2024 | 195.57B |
| March 26, 2024 | 195.57B |
| March 25, 2024 | 195.57B |
| March 22, 2024 | 197.02B |
| March 21, 2024 | 197.02B |
| March 20, 2024 | 192.26B |
| March 19, 2024 | 198.07B |
| March 18, 2024 | 204.40B |
| March 15, 2024 | 204.40B |
| March 14, 2024 | 204.40B |
| March 13, 2024 | 200.52B |
| March 12, 2024 | 200.97B |
| March 11, 2024 | 201.84B |
| March 08, 2024 | 208.48B |
| March 07, 2024 | 208.48B |
| March 06, 2024 | 208.48B |
| March 05, 2024 | 208.48B |
| March 04, 2024 | 208.48B |
| March 01, 2024 | 208.48B |
| February 29, 2024 | 206.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
129.58B
Minimum
Mar 18 2020
222.80B
Maximum
Jan 23 2024
168.15B
Average
166.04B
Median
May 14 2021
Market Cap Benchmarks
| Sandoz Group AG | 15.47B |
| Roche Holding AG | 197.40B |
| Bristol-Myers Squibb Co | 91.08B |
| ADC Therapeutics SA | 355.27M |
Market Cap Related Metrics
| PE Ratio | 13.91 |
| PS Ratio | 4.239 |
| PEG Ratio | 0.1109 |
| Price to Book Value | 5.245 |
| Price to Free Cash Flow | 20.65 |
| Price | 101.99 |
| Earnings Yield | 7.19% |
| PEGY Ratio | 0.1075 |
| Operating PE Ratio | 19.90 |
| Normalized PE Ratio | 23.07 |